Overview - KALA US

Kala Pharmaceuticals Inc

KALA.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

KALA BIO, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of eye diseases. The company's product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development product, including KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.

symbol	last	change	%chng	name	mcap	sector	wiki
KALA				Kala Pharmaceuticals Inc	0.021B	Healthcare

	symbol	prev.close	range	chart	target	percent	period	months	due	rating
D	KALA	6.30	0,-1.886,-0.500,-0.208,-1.886	8.28,7.14,7.02,7.05,7.06,7.34,7.22,7.49,7.64,7.87,7.90,7.82,7.36,6.82,6.37	4.33-6.73	-12.15%	267,114,267	5.1	Jan 4-Sep 27	39.58%

Intraday chart for KALA

Please reload the page if latest figures not showing

Key financials

The following extracted figures are selected by the AI as the most essential for predicting future price movements. The arrows show the how the AI thinks the figure affects the stock price (not the change in the figure)

. operatingIncome	-9M
. . netInterestIncome	-1M
. incomeBeforeTax	-9M
. otherOperatingExpenses	9M
. netIncomeApplicableToCommonShares

. reconciledDepreciation	0M
. netWorkingCapital	45M
. netInvestedCapital	42M
. netDebt	-15M
. totalCashFromOperatingActivities	-8M
. freeCashFlow. .	-8M

News for KALA

Ancient Pillar, Idols Unearthed In Varanasi's Bhandaha Kala | Varanasi News - indiatimes
6h ago - KALA - story

headline news | recent news | latest news | market news

Chart KALA

Similar stocks g.trial preclinical

Kadmon Holdings Inc	KDMN	US	Healthcare	20.823	1696M	-
Calyxt Inc	CLXT	US	Consumer Cyclical	33.7141	31M	-
Forte Biosciences Inc	FBRX	US	Healthcare	22.2808	25M	-
OncoCyte Corp	OCX	US	Healthcare	17.4791	24M	-
Kala Pharmaceuticals Inc	KALA	US	Healthcare	23.7877	21M	-
Synlogic Inc	SYBX	US	Healthcare	56.2321	21M	-
Yumanity Therapeutics Inc	YMTX	US	Healthcare	6.74619	21M	-
Aptevo Therapeutics Inc	APVO	US	Healthcare	6.93563	3M	-
Sientra Inc	SIEN	US	Healthcare	20.3709	2M	-

Myshare aims to provide good clear honest and easy analysis of financial markets using a scientific, teaching and informative approach. We try hard but please read our disclaimer. Pages are provided by ourselves and our users. Register to edit pages and see the documentation

Global news | headline news | recent news | latest news | market news | topics | stock topics

News topics and stories from around the world and in the selected country

US News | headline news | recent news | latest news | market news | recent topics | stock topics

News from major news outlets like BBC, CNN and Reuters

Forecasts | Forecast buy | Forecast sell | Forecast up | Forecast down | Forecast sector

Long term stock predictions using AI reading the financial accounts of each company.

``` ``` ``` ```